These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21828198)

  • 1. H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study.
    Farez MF; Ysrraelit MC; Fiol M; Correale J
    Mult Scler; 2012 Feb; 18(2):254-6. PubMed ID: 21828198
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pearls for H1N1 influenza vaccination.
    Marcotte GV
    J Allergy Clin Immunol; 2010 Apr; 125(4):951-2; author reply 952. PubMed ID: 20226509
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
    Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
    Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination.
    Denholm JT; Neal A; Yan B; Petty S; Knox J; French C; Marshall C
    Neurology; 2010 Dec; 75(24):2246-8. PubMed ID: 21172848
    [No Abstract]   [Full Text] [Related]  

  • 5. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
    Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of fatal adverse events after H1N1 influenza vaccination.
    Nakada H; Narimatsu H; Tsubokura M; Murashige N; Matsumura T; Kodama Y; Kishi Y; Kami M
    Clin Infect Dis; 2010 Jun; 50(11):1548-9. PubMed ID: 20433361
    [No Abstract]   [Full Text] [Related]  

  • 7. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
    Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P
    Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
    Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse of nephrotic syndrome following the use of 2009 pandemic influenza A (H1N1) vaccine.
    Fernandes P; Jorge S; Lopes JA
    Am J Kidney Dis; 2010 Jul; 56(1):185-6. PubMed ID: 20620684
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.
    Auriel E; Regev K; Dori A; Karni A
    Muscle Nerve; 2011 Jun; 43(6):893-4. PubMed ID: 21607970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccination and hemostasis: no sustainable procoagulant effects from 2009 H1N1 influenza vaccine in healthy healthcare workers.
    Smit PM; Veldhuis S; Mulder JW; Roggeveen C; Rimmelzwaan GF; Meijers JC; Beijnen JH; Brandjes DP
    J Thromb Haemost; 2011 Aug; 9(8):1659-61. PubMed ID: 21696536
    [No Abstract]   [Full Text] [Related]  

  • 12. Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a french teaching hospital.
    Tanguy M; Boyeau C; Pean S; Marijon E; Delhumeau A; Fanello S
    Vaccine; 2011 Jun; 29(25):4190-4. PubMed ID: 21497636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand.
    Kiertiburanakul S; Malathum K; Watcharananan SP; Bunupuradah P; Piebpien P; Rujiraviroj U; Likitsinsipon W; Apivanich S; Kehachindawat P; Burakitcharoen R; Leelaudomlipi S; Wananukul W
    Am J Infect Control; 2011 Aug; 39(6):525-8. PubMed ID: 21612842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pandemic vaccines].
    Floret D
    Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
    [No Abstract]   [Full Text] [Related]  

  • 16. [Egg allergy and vaccine against the new influenza. A plan of action in Ostergotland].
    Kronander UN; Nilsson L
    Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3230. PubMed ID: 20101832
    [No Abstract]   [Full Text] [Related]  

  • 17. 2009 H1N1 influenza vaccines in pregnant women: the French Pharmacovigilance survey.
    Lacroix I; Damase-Michel C; Kreft-Jais C; Castot A; Montastruc JL;
    Vaccine; 2011 Feb; 29(7):1357-8. PubMed ID: 21185422
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
    Enserink M
    Science; 2009 Nov; 326(5955):922. PubMed ID: 19965485
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.
    Stowe J; Andrews N; Bryan P; Seabroke S; Miller E
    Vaccine; 2011 Nov; 29(51):9467-72. PubMed ID: 22019757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.